Literature DB >> 7751847

Non-enzymatic glycation of peripheral nerve proteins in human diabetics.

C Ryle1, M Donaghy.   

Abstract

We have measured non-enzymatic glycation of proteins in the cytoskeletal and myelin fractions of nerve fascicles from human sural nerves obtained from diabetic and non-diabetic amputation specimens. Levels of the early reversible glycation adduct, measured as furosine did not differ significantly between diabetics and controls in either protein fraction. Pentosidine levels per unit protein were significantly elevated in diabetics relative to controls in both cytoskeletal (5.96 vs 4.47; p = 0.037) and myelin protein (1.35 vs 0.69; p = 0.023) fractions. Protein cross-linkage in the cytoskeletal fraction, probably due to AGEs, was also higher in diabetics than controls (504 vs 349; p = 0.057). These results show that increased AGE accumulation occurs in cytoskeletal, as well as myelin, peripheral nerve proteins in diabetics. This suggests a possible new mechanism contributing to the axonal degeneration polyneuropathy of diabetes which is based upon irreversible glycation of axonal cytoskeletal proteins causing their cross-linkage and altered function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751847     DOI: 10.1016/0022-510x(94)00251-i

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

Review 2.  The role of glycation in the pathogenesis of diabetic polyneuropathy.

Authors:  R H King
Journal:  Mol Pathol       Date:  2001-12

3.  Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy.

Authors:  James Welsh; Jimmy Thomas; Deep Shah; Pamela K Allen; Xiong Wei; Kevin Mitchell; Song Gao; Peter Balter; Ritsuko Komaki; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-11       Impact factor: 7.038

Review 4.  The role of axonal cytoskeleton in diabetic neuropathy.

Authors:  W G McLean
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

5.  Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis.

Authors:  S M Chou; H S Wang; A Taniguchi; R Bucala
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

Review 6.  Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies.

Authors:  Filipa I Baptista; Helena Pinheiro; Catarina A Gomes; António F Ambrósio
Journal:  Mol Neurobiol       Date:  2018-07-12       Impact factor: 5.590

7.  Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes.

Authors:  Baqiyyah N Conway; Vanita R Aroda; John D Maynard; Nathaniel Matter; Stephen Fernandez; Robert E Ratner; Trevor J Orchard
Journal:  Diabetes Care       Date:  2011-02-09       Impact factor: 19.112

Review 8.  Cutaneous pain in disorders affecting peripheral nerves.

Authors:  Cheryl L Stucky; Alexander R Mikesell
Journal:  Neurosci Lett       Date:  2021-10-01       Impact factor: 3.046

9.  Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study.

Authors:  D Vasudevan; Manoj M Naik; Qayum I Mukaddam
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

10.  Assessment of Diabetic Polyneuropathy in Inpatient Care: Fasting Blood Glucose, HbA1c, Electroneuromyography and Diabetes Risk Factors.

Authors:  Enra Suljic; Igor Kulasin; Vanja Alibegovic
Journal:  Acta Inform Med       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.